37 related articles for article (PubMed ID: 21915031)
1. SOX2 and nestin expression in human melanoma: an immunohistochemical and experimental study.
Laga AC; Zhan Q; Weishaupt C; Ma J; Frank MH; Murphy GF
Exp Dermatol; 2011 Apr; 20(4):339-45. PubMed ID: 21410764
[TBL] [Abstract][Full Text] [Related]
2. Comparative Quantitative Proteomic Analysis of Melanoma Subtypes, Nevus-Associated Melanoma, and Corresponding Nevi.
Naimy S; Sølberg JBK; Kuczek DE; Løvendorf MB; Bzorek M; Litman T; Mund A; Rahbek Gjerdrum LM; Clark RA; Mann M; Dyring-Andersen B
J Invest Dermatol; 2024 Jan; ():. PubMed ID: 38185415
[TBL] [Abstract][Full Text] [Related]
3. The Clinical and Theranostic Values of Activated Leukocyte Cell Adhesion Molecule (ALCAM)/CD166 in Human Solid Cancers.
Yang Y; Sanders AJ; Dou QP; Jiang DG; Li AX; Jiang WG
Cancers (Basel); 2021 Oct; 13(20):. PubMed ID: 34680335
[TBL] [Abstract][Full Text] [Related]
4. Molecular pathology of cutaneous melanoma.
van Kempen LC; Redpath M; Robert C; Spatz A
Melanoma Manag; 2014 Nov; 1(2):151-164. PubMed ID: 30190820
[TBL] [Abstract][Full Text] [Related]
5. Expression of Phosphatase and Tensin Homologue, phospho-Akt, and p53 in Acral Benign and Malignant Melanocytic Neoplasms (Benign Nevi, Dysplastic Nevi, and Acral Melanomas).
Lyu SM; Wu JY; Byun JY; Choi HY; Park SH; Choi YW
Ann Dermatol; 2016 Oct; 28(5):548-554. PubMed ID: 27746632
[TBL] [Abstract][Full Text] [Related]
6. Association between tumorigenic potential and the fate of cancer cells in a syngeneic melanoma model.
Krelin Y; Berkovich L; Amit M; Gil Z
PLoS One; 2013; 8(4):e62124. PubMed ID: 23626777
[TBL] [Abstract][Full Text] [Related]
7. Cell proliferation in cutaneous malignant melanoma: relationship with neoplastic progression.
Piérard GE
ISRN Dermatol; 2012; 2012():828146. PubMed ID: 22363864
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical characteristics of melanoma.
Ohsie SJ; Sarantopoulos GP; Cochran AJ; Binder SW
J Cutan Pathol; 2008 May; 35(5):433-44. PubMed ID: 18399807
[TBL] [Abstract][Full Text] [Related]
9. Pitfalls in the evaluation of melanocytic lesions.
Brenn T
Histopathology; 2012 Apr; 60(5):690-705. PubMed ID: 22176022
[TBL] [Abstract][Full Text] [Related]
10. Tissue microarray analysis of ezrin, KBA.62, CD166, nestin, and p-Akt in melanoma versus banal and atypical nevi, and nonmelanocytic lesions.
Shanesmith RP; Smart C; Cassarino DS
Am J Dermatopathol; 2011 Oct; 33(7):663-8. PubMed ID: 21915031
[TBL] [Abstract][Full Text] [Related]
11. Potentially useful markers for desmoplastic melanoma: an analysis of KBA.62, p-AKT, and ezrin.
Bernaba BN; Vogiatzis PI; Binder SW; Cassarino DS
Am J Dermatopathol; 2011 Jun; 33(4):333-7; quiz 338-40. PubMed ID: 21610456
[TBL] [Abstract][Full Text] [Related]
12. Increased expression of stem cell markers in malignant melanoma.
Klein WM; Wu BP; Zhao S; Wu H; Klein-Szanto AJ; Tahan SR
Mod Pathol; 2007 Jan; 20(1):102-7. PubMed ID: 17143262
[TBL] [Abstract][Full Text] [Related]
13. Nestin expression in cutaneous melanomas and melanocytic nevi.
Brychtova S; Fiuraskova M; Hlobilková A; Brychta T; Hirnak J
J Cutan Pathol; 2007 May; 34(5):370-5. PubMed ID: 17448190
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic utility of neural stem and progenitor cell markers nestin and SOX2 in distinguishing nodal melanocytic nevi from metastatic melanomas.
Chen PL; Chen WS; Li J; Lind AC; Lu D
Mod Pathol; 2013 Jan; 26(1):44-53. PubMed ID: 22899289
[TBL] [Abstract][Full Text] [Related]
15. Cdc7 expression in melanomas, Spitz tumors and melanocytic nevi.
Clarke LE; Fountaine TJ; Hennessy J; Bruggeman RD; Clarke JT; Mauger DT; Helm KF
J Cutan Pathol; 2009 Apr; 36(4):433-8. PubMed ID: 19278428
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
